doi: 10.1007/s00395-021-00873-9 39 YangXQiangQLiNFengPWeiWHolscherC
Borbath and coworkers [82] reported the case of a 51-year-old woman who received 10 mg/kg VPA daily to prevent seizures after a neurosurgical procedure, and who developed VHE (ammonia concentration 234 mol/l) without any sign of hepatic dysfunction
The GLP-1 Market is expected to witness substantial growth as pharmaceutical companies accelerate R&D efforts, expand manufacturing capacity, and compete to develop next-generation therapies for obesity and metabolic disorders
It helps regulate the movement of potassium ions across cell membranes, ensuring proper distribution and preventing abnormalities associated with potassium imbalances
1 This insulin secretion causes an overall decrease in blood sugar levels, reduces the production of glucagon, which prevents the release of glucose storage from the liver, and induces a satiety response that elevates insulin sensitivity and causes weight loss